Biotech
-
16.3KHTBX Stock: The Solution Is T-Cells Not Antibodies
No one ever said investing is easy. The key is doing lots of research and finding momentum BEFORE it happens. We did...
-
4.8KATOS Stock: What’s Happening?
ATOS stock is a name that we covered on and off since 2017. Except for a few price spikes, ATOS stock has been...
-
10.8KVBI Vaccines Stock Destined For New Highs
VBI Vaccines stock has dropped along with the other COVID-19 vaccine players after Russia announced it developed a coronavirus vaccine. Like many...
-
23.8KSorrento Therapeutics Stock: Ignore Hindenburg
A thorn in the side of longs continues to be Hindenburg Research. Whenever a hot stock starts climbing, Hindenburg goes short and...
-
7.4KBCRX Stock Just Gave A Clear Buy Signal
BCRX stock ran to $6 after re-initiated coverage last month, which you can read here. Since then, BCRX has dropped back down...
-
17.5K2Wading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
-
16.0KWhy VXRT Stock Is Heading Higher
Price action is very important when it comes to trading and investing. On a day when COVID-19 vaccine plays dropped on the...
-
20.2KWhy Sorrento Stock Can Keep Running
We hate to keep patting ourselves on the back as we have become a thorn in the short’s side with our market...
-
12.2KWhat’s The Latest With T2 Biosystems Stock?
We alerted our subscribers about T2 Biosystems stock back in March before the big run from $.23 a share. Now many of our...
-
7.7KWill The Momentum In BIOC Stock Continue?
BIOC stock is a name that we have covered on and off since 2017. Overall, BIOC stock has been a horrible investment since,...
